DK1015441T3 - Fremgangsmåde til fremstilling af 4-hydroxy-2-oxo-pyranderivater, der er nyttige som proteaseinhibitorer - Google Patents

Fremgangsmåde til fremstilling af 4-hydroxy-2-oxo-pyranderivater, der er nyttige som proteaseinhibitorer

Info

Publication number
DK1015441T3
DK1015441T3 DK98945806T DK98945806T DK1015441T3 DK 1015441 T3 DK1015441 T3 DK 1015441T3 DK 98945806 T DK98945806 T DK 98945806T DK 98945806 T DK98945806 T DK 98945806T DK 1015441 T3 DK1015441 T3 DK 1015441T3
Authority
DK
Denmark
Prior art keywords
hydroxy
oxopyran
preparation
protease inhibitors
derivatives useful
Prior art date
Application number
DK98945806T
Other languages
English (en)
Inventor
James R Gage
Robert C Kelly
Bradley D Hewitt
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Application granted granted Critical
Publication of DK1015441T3 publication Critical patent/DK1015441T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
    • C07C205/56—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups bound to carbon atoms of six-membered aromatic rings and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/30—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation with halogen containing compounds, e.g. hypohalogenation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00—Compounds having —CHO groups
    • C07C47/20—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms
    • C07C47/277—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
    • C07C59/48—Unsaturated compounds containing hydroxy or O-metal groups containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/32—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK98945806T 1997-09-11 1998-09-03 Fremgangsmåde til fremstilling af 4-hydroxy-2-oxo-pyranderivater, der er nyttige som proteaseinhibitorer DK1015441T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5861897P 1997-09-11 1997-09-11
PCT/US1998/017993 WO1999012919A1 (en) 1997-09-11 1998-09-03 Process to produce 4-hydroxy-2-oxo-pyrane derivates useful as protease inhibitors

Publications (1)

Publication Number Publication Date
DK1015441T3 true DK1015441T3 (da) 2004-07-26

Family

ID=22017924

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98945806T DK1015441T3 (da) 1997-09-11 1998-09-03 Fremgangsmåde til fremstilling af 4-hydroxy-2-oxo-pyranderivater, der er nyttige som proteaseinhibitorer

Country Status (21)

Country Link
US (2) US6077963A (da)
EP (1) EP1015441B1 (da)
JP (3) JP4462760B2 (da)
KR (1) KR100569771B1 (da)
CN (3) CN100471832C (da)
AT (1) ATE266654T1 (da)
CA (1) CA2300204C (da)
CZ (1) CZ298847B6 (da)
DE (1) DE69823844T2 (da)
DK (1) DK1015441T3 (da)
ES (1) ES2221199T3 (da)
FI (1) FI120973B (da)
HK (3) HK1030418A1 (da)
HU (1) HU228986B1 (da)
NO (1) NO321835B1 (da)
NZ (1) NZ503338A (da)
PL (1) PL193240B1 (da)
PT (1) PT1015441E (da)
RU (2) RU2223958C2 (da)
SK (1) SK284974B6 (da)
WO (1) WO1999012919A1 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3699100A (en) * 1999-03-18 2000-10-04 Pharmacia & Upjohn Company Improved process for asymmetric hydrogenation
US6552204B1 (en) * 2000-02-04 2003-04-22 Roche Colorado Corporation Synthesis of 3,6-dialkyl-5,6-dihydro-4-hydroxy-pyran-2-one
US6500963B2 (en) 2001-02-22 2002-12-31 Boehringer Ingelheim Pharma Kg Process for preparing optically active dihydropyrones
DE10108470A1 (de) * 2001-02-22 2002-09-05 Boehringer Ingelheim Pharma Verfahren zur Herstellung optisch aktiver Dihydropyrone
US6987123B2 (en) 2001-07-26 2006-01-17 Cadila Healthcare Limited Heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine
EP1481961B1 (en) 2002-02-07 2009-11-25 Sumitomo Chemical Company, Limited Process for producing (r)-3-hydroxy-3-(2-phenylethyl)hexanoic acid and its intermediate
DE10313118A1 (de) 2003-03-24 2004-10-07 Boehringer Ingelheim Pharma Gmbh & Co. Kg Enantioselektive Hydrierung von Intermediaten bei der Tipranavir-Synthese
US7512945B2 (en) * 2003-12-29 2009-03-31 Intel Corporation Method and apparatus for scheduling the processing of commands for execution by cryptographic algorithm cores in a programmable network processor
CN100448836C (zh) * 2005-06-03 2009-01-07 浙江中贝化工有限公司 一种抗艾滋病药物关键中间体的制备方法
US7807838B2 (en) * 2005-08-24 2010-10-05 Pfizer Inc. Methods for the preparation of HCV polymerase inhibitors
KR101548306B1 (ko) * 2007-11-30 2015-08-28 가부시키가이샤 한도오따이 에네루기 켄큐쇼 발광 소자, 발광 장치 및 전자기기
US8853393B2 (en) * 2011-07-29 2014-10-07 Anhui New Star Pharmaceutical Development Co., Ltd. Intermediate for preparing tapentadol or analogues thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1355668A (fr) * 1963-02-05 1964-03-20 Moteur rotatif à combustion interne perfectionné
FR1355667A (fr) * 1963-02-05 1964-03-20 Meci Materiel Elect Contr Gaine tubulaire pour électrode servant à la mesure du ph
FR2096877B1 (da) * 1970-07-09 1973-08-10 Hexachimie
JPH0665657B2 (ja) * 1984-11-08 1994-08-24 日本化薬株式会社 光学活性マンデル酸の製法
JPH072677B2 (ja) * 1988-02-19 1995-01-18 株式会社クラレ （±）―２―ヒドロキシ―４―フェニルブタン酸の光学分割法
JPH01221345A (ja) * 1988-02-27 1989-09-04 Ajinomoto Co Inc マンデル酸誘導体の光学分割方法
JP3084577B2 (ja) * 1991-09-27 2000-09-04 山川薬品工業株式会社 光学活性なアトロラクチン酸の製造方法および製造の中間体
JP3178086B2 (ja) * 1992-06-17 2001-06-18 山川薬品工業株式会社 光学活性α−メチルベンジルアミンの製造方法
ZA938019B (en) * 1992-11-13 1995-04-28 Upjohn Co Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating HIV and other retroviruses
RU2140917C1 (ru) * 1993-11-19 1999-11-10 Парк, Дэвис энд Компани Производные 5,6-дигидропирона и фармацевтическая композиция на их основе
IL129871A (en) * 1994-05-06 2003-11-23 Pharmacia & Upjohn Inc Process for preparing 4-phenyl-substituted octanoyl-oxazolidin-2-one intermediates that are useful for preparing pyran-2-ones useful for treating retroviral infections

Also Published As

Publication number Publication date
HUP0003593A3 (en) 2002-12-28
CZ2000804A3 (cs) 2000-08-16
ES2221199T3 (es) 2004-12-16
PL193240B1 (pl) 2007-01-31
CN1268947A (zh) 2000-10-04
CZ298847B6 (cs) 2008-02-27
CA2300204A1 (en) 1999-03-18
HK1063776A1 (en) 2005-01-14
RU2003131081A (ru) 2005-04-10
HUP0003593A2 (hu) 2001-02-28
CN1511820A (zh) 2004-07-14
KR100569771B1 (ko) 2006-04-11
EP1015441A1 (en) 2000-07-05
US6265604B1 (en) 2001-07-24
AU743496B2 (en) 2002-01-24
US6077963A (en) 2000-06-20
RU2263106C2 (ru) 2005-10-27
HU228986B1 (en) 2013-07-29
RU2223958C2 (ru) 2004-02-20
ATE266654T1 (de) 2004-05-15
NZ503338A (en) 2002-03-01
PT1015441E (pt) 2004-08-31
FI20000553A (fi) 2000-03-10
JP2010090157A (ja) 2010-04-22
FI120973B (fi) 2010-05-31
KR20010023864A (ko) 2001-03-26
SK284974B6 (sk) 2006-03-02
NO321835B1 (no) 2006-07-10
DE69823844D1 (de) 2004-06-17
NO20001274L (no) 2000-05-10
JP5266194B2 (ja) 2013-08-21
JP4462760B2 (ja) 2010-05-12
CN1284763C (zh) 2006-11-15
CN1990452A (zh) 2007-07-04
WO1999012919A1 (en) 1999-03-18
DE69823844T2 (de) 2005-04-14
JP2009138002A (ja) 2009-06-25
JP5016621B2 (ja) 2012-09-05
CA2300204C (en) 2006-12-12
JP2001515895A (ja) 2001-09-25
HK1030418A1 (en) 2001-05-04
CN100471832C (zh) 2009-03-25
PL339138A1 (en) 2000-12-04
SK2262000A3 (en) 2000-10-09
CN1298714C (zh) 2007-02-07
HK1104027A1 (en) 2008-01-04
AU9296598A (en) 1999-03-29
NO20001274D0 (no) 2000-03-10
EP1015441B1 (en) 2004-05-12

Similar Documents

Publication Publication Date Title
HK1104027A1 (en) Compounds useful to produce a protease inhibitor
NO950550L (no) Sulfonylalkanoylamino-hydroksyetylaminosulfonamider som er nyttige som retrovirale proteaseinhibitorer
ATE271034T1 (de) Sulfonylalkanoylamino-hydroxyethylamino- sulfonamide als inhibitoren der retroviralen protease
EA199700221A1 (ru) Замещенный аминокислотой гидроксиэтиламиносульфонамид в качестве ингибиторов ретровирусной протеазы
DK0558603T3 (da) Retrovirale proteaseinhibitorer
DK0813543T3 (da) Bis-aminosyrehydroxyethylaminsulfonamider som inhibitorer af retrovirale proteaser
DK0749421T3 (da) Sulfonamidderivater som aspartylproteaseinhibitorer
DK172389D0 (da) Hiv-proteaseinhibitorer, der er nyttige til behandling af aids
DK0885881T3 (da) Sulfonylalkanoylaminohydroxyethylaminosulfaminsyrer, der er anvendelige som retrovirale proteaseinhibitorer
DK0804410T3 (da) Fremgangsmåde til fremstilling af retrovirale proteaseinhibitor-mellemprodukter
DK0891341T3 (da) 1,3,4-Oxadiazinderivater samt deres anvendelse som pesticider
MY132553A (en) Methods of making hiv-protease inhibitors and intermediates for making hiv-protease inhibitors
DK0666841T3 (da) Succinoylamino-hydroxyethylaminosulfaminsyrederivater til anvendelse som inhibitorer af retrovirale proteaser
AP2003002938A0 (en) Intermediates for making HIV- protease inhibitors and methods of making HIV protease inhibitors.